CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,991,980
- in 20 filings, $60.0M under 10b5-1 plans
Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 82 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-31 | Horn Margaret A Chief Operating Officer | Exercise or conversion 10b5-1 | +10,000 | $4.09 | $41K | 109,474 |
| 2023-08-31 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −10,000 | $34.05 | $340K | 99,474 |
| 2023-08-31 | Horn Margaret A Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −10,000 | 108,302 | ||
| 2023-08-15 | Horn Margaret A Chief Operating Officer | Exercise or conversion 10b5-1 | +5,000 | $4.09 | $20K | 104,474 |
| 2023-08-15 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −3,085 | $30.36 | $94K | 101,389 |
| 2023-08-15 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −1,915 | $30.80 | $59K | 99,474 |
| 2023-08-15 | Horn Margaret A Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,000 | 118,302 | ||
| 2023-08-02 | Kelsey Stephen Michael | Sale 10b5-1 | −16,666 | $32.40 | $540K | 292,448 |
| 2023-08-01 | Kelsey Stephen Michael | Sale 10b5-1 | −16,666 | $29.19 | $487K | 309,114 |
| 2023-07-31 | Cislini Jeff General Counsel | Sale 10b5-1 | −1,500 | $26.02 | $39K | 43,227 |
| 2023-06-20 | Kelsey Stephen Michael | Sale | −2,102 | $24.89 | $52K | 325,780 |
| 2023-06-20 | Horn Margaret A Chief Operating Officer | Sale | −2,102 | $24.89 | $52K | 99,474 |
| 2023-06-20 | Anders Jack Chief Financial Officer | Sale | −1,249 | $24.89 | $31K | 55,094 |
| 2023-06-20 | Cislini Jeff General Counsel | Sale | −1,239 | $25.14 | $31K | 44,727 |
| 2023-06-08 | Borellini Flavia Director | Grant or award | +5,200 | 17,634 | ||
| 2023-06-08 | Borellini Flavia Director | Grant or award · Stock Option (Right to Buy) | +18,400 | 18,400 | ||
| 2023-06-08 | Borisy Alexis Director | Grant or award | +5,200 | 239,822 | ||
| 2023-06-08 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +18,400 | 18,400 | ||
| 2023-06-08 | Weber Barbara Director | Grant or award | +5,200 | 15,825 | ||
| 2023-06-08 | Weber Barbara Director | Grant or award · Stock Option (Right to Buy) | +18,400 | 18,400 |
Page 32 of 39 · 775 trades